KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Receivables - Net (2016 - 2025)

Neogenomics (NEO) has disclosed Receivables - Net for 16 consecutive years, with $159.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 5.78% year-over-year to $159.2 million, compared with a TTM value of $159.2 million through Dec 2025, up 5.78%, and an annual FY2025 reading of $159.2 million, up 5.78% over the prior year.
  • Receivables - Net was $159.2 million for Q4 2025 at Neogenomics, up from $155.3 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $159.2 million in Q4 2025 and bottomed at $102.9 million in Q1 2021.
  • Average Receivables - Net over 5 years is $129.8 million, with a median of $128.3 million recorded in 2023.
  • Peak annual rise in Receivables - Net hit 21.1% in 2021, while the deepest fall reached 1.22% in 2021.
  • Year by year, Receivables - Net stood at $112.1 million in 2021, then increased by 6.76% to $119.7 million in 2022, then rose by 9.62% to $131.2 million in 2023, then rose by 14.72% to $150.5 million in 2024, then grew by 5.78% to $159.2 million in 2025.
  • Business Quant data shows Receivables - Net for NEO at $159.2 million in Q4 2025, $155.3 million in Q3 2025, and $153.1 million in Q2 2025.